Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 14, 2020

Total Value: $94.56M (96.9% shares, 3.1% debt)

Holdings (27)

LGND LIGAND PHARMACEUTICALS 12.4%

Value $11.7M Shares 160,919 Share Price $72.72 * Est. Cost/Share $56.68 Unrealized @ Report Date 0.0%

— IVERIC BIO INC 9.4%

Value $8.888M Shares 2,583,786 Share Price $3.44 Est. Cost/Share $1.30 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 6.3%

Value $5.916M Shares 6,430,637 Share Price $0.92 Est. Cost/Share $2.16 Unrealized @ Report Date —

— AMARIN CORP PLC -ADR 5.6%

Value $5.252M Shares 1,313,100 Share Price $4.00 Est. Cost/Share $9.14 Unrealized @ Report Date —

— AFFIMED NV 5.0%

Value $4.74M Shares 3,000,000 Share Price $1.58 Est. Cost/Share $2.75 Unrealized @ Report Date —

— CATALYST BIOSCIENCES INC 4.7%

Value $4.454M Shares 1,019,196 Share Price $4.37 Est. Cost/Share $5.11 Unrealized @ Report Date —

— STEMLINE THERAPEUTICS INC 4.5%

Value $4.291M Shares 886,632 Share Price $4.84 Est. Cost/Share $4.84 Unrealized @ Report Date —

XOMA XOMA CORP 4.5%

Value $4.245M Shares 208,600 Share Price $20.35 * Est. Cost/Share $14.24 Unrealized @ Report Date +62.1%

— OPIANT PHARMACEUTICALS INC 3.9%

Value $3.649M Shares 380,948 Share Price $9.58 Est. Cost/Share $15.15 Unrealized @ Report Date —

— NEOS THERAPEUTICS INC 3.7%

Value $3.518M Shares 4,690,146 Share Price $0.75 Est. Cost/Share $1.80 Unrealized @ Report Date —

— OXFORD IMMUNOTEC GLOBAL PLC 3.7%

Value $3.467M Shares 374,431 Share Price $9.26 Est. Cost/Share $16.13 Unrealized @ Report Date —

EOLS EVOLUS INC 3.6%

Value $3.415M Shares 822,960 Share Price $4.15 * Est. Cost/Share $11.17 Unrealized @ Report Date -24.2%

— ADAMAS PHARMACEUTICALS INC 3.6%

Value $3.361M Shares 1,162,876 Share Price $2.89 Est. Cost/Share $4.81 Unrealized @ Report Date —

CPIX CUMBERLAND PHARMACEUTICALS 3.5%

Value $3.295M Shares 907,735 Share Price $3.63 * Est. Cost/Share $5.80 Unrealized @ Report Date -22.9%

— APOLLO ENDOSURGERY INC 3.4%

Value $3.233M Shares 1,683,861 Share Price $1.92 Est. Cost/Share $4.35 Unrealized @ Report Date —

— CIDARA THERAPEUTICS INC 3.4%

Value $3.231M Shares 1,302,981 Share Price $2.48 Est. Cost/Share $2.48 Unrealized @ Report Date —

— AEGERION PHARMACEUTICALSAEGR 5 04/01/25 3.1%

Value $2.886M Shares 3,037,627 Share Price $0.95 Est. Cost/Share $0.95 Unrealized @ Report Date —

— BIODELIVERY SCIENCES INTL 3.0%

Value $2.861M Shares 755,000 Share Price $3.79 Est. Cost/Share $3.79 Unrealized @ Report Date —

— CHIASMA INC 2.9%

Value $2.716M Shares 744,134 Share Price $3.65 Est. Cost/Share $3.97 Unrealized @ Report Date —

DMAC DIAMEDICA THERAPEUTICS INC 2.4%

Value $2.311M Shares 825,297 Share Price $2.80 * Est. Cost/Share $4.13 Unrealized @ Report Date 0.0%

— SEASPINE HOLDINGS CORP 2.2%

Value $2.068M Shares 253,131 Share Price $8.17 Est. Cost/Share $8.17 Unrealized @ Report Date —

— APPLIED GENETIC TECHNOLOGIES 2.0%

Value $1.925M Shares 586,969 Share Price $3.28 Est. Cost/Share $3.28 Unrealized @ Report Date —

— BAUDAX BIO INC 1.6%

Value $1.513M Shares 610,200 Share Price $2.48 Est. Cost/Share $2.48 Unrealized @ Report Date —

IDXG INTERPACE BIOSCIENCES INC 1.0%

Value $924K Shares 178,295 Share Price $5.18 Est. Cost/Share $0.50 Unrealized @ Report Date —

— ANTARES PHARMA INC 0.4%

Value $357K Shares 151,189 Share Price $2.36 Est. Cost/Share $2.36 Unrealized @ Report Date —

— HTG MOLECULAR DIAGNOSTICS 0.3%

Value $323K Shares 992,641 Share Price $0.33 Est. Cost/Share $1.63 Unrealized @ Report Date —

— RIGEL PHARMACEUTICALS INC 0.0%

Value $16,000 Shares 10,000 Share Price $1.60 Est. Cost/Share $1.60 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
LGND	LIGAND PHARMACEUTICALS	160,919	$11.7M	12.4%	$72.72 *	$56.68	0.0%	COM NEW	53220K504
—	IVERIC BIO INC	2,583,786	$8.888M	9.4%	$3.44	$1.30	—	COM	46583P102
—	CTI BIOPHARMA CORP	6,430,637	$5.916M	6.3%	$0.92	$2.16	—	COM	12648L601
—	AMARIN CORP PLC -ADR	1,313,100	$5.252M	5.6%	$4.00	$9.14	—	SPONS ADR NEW	023111206
—	AFFIMED NV	3,000,000	$4.74M	5.0%	$1.58	$2.75	—	COM	N01045108
—	CATALYST BIOSCIENCES INC	1,019,196	$4.454M	4.7%	$4.37	$5.11	—	COM NEW	14888D208
—	STEMLINE THERAPEUTICS INC	886,632	$4.291M	4.5%	$4.84	$4.84	—	COM	85858C107
XOMA	XOMA CORP	208,600	$4.245M	4.5%	$20.35 *	$14.24	+62.1%	COM	98419J206
—	OPIANT PHARMACEUTICALS INC	380,948	$3.649M	3.9%	$9.58	$15.15	—	COM	683750103
—	NEOS THERAPEUTICS INC	4,690,146	$3.518M	3.7%	$0.75	$1.80	—	COM	64052L106
—	OXFORD IMMUNOTEC GLOBAL PLC	374,431	$3.467M	3.7%	$9.26	$16.13	—	ORD SHS	G6855A103
EOLS	EVOLUS INC	822,960	$3.415M	3.6%	$4.15 *	$11.17	-24.2%	COM	30052C107
—	ADAMAS PHARMACEUTICALS INC	1,162,876	$3.361M	3.6%	$2.89	$4.81	—	COM	00548A106
CPIX	CUMBERLAND PHARMACEUTICALS	907,735	$3.295M	3.5%	$3.63 *	$5.80	-22.9%	COM	230770109
—	APOLLO ENDOSURGERY INC	1,683,861	$3.233M	3.4%	$1.92	$4.35	—	COM	03767D108
—	CIDARA THERAPEUTICS INC	1,302,981	$3.231M	3.4%	$2.48	$2.48	—	COM	171757107
—	AEGERION PHARMACEUTICALSAEGR 5 04/01/25	3,037,627	$2.886M	3.1%	$0.95	$0.95	—	NOTE 5.000% 4/0	00767EAC6
—	BIODELIVERY SCIENCES INTL	755,000	$2.861M	3.0%	$3.79	$3.79	—	COM	09060J106
—	CHIASMA INC	744,134	$2.716M	2.9%	$3.65	$3.97	—	COM	16706W102
DMAC	DIAMEDICA THERAPEUTICS INC	825,297	$2.311M	2.4%	$2.80 *	$4.13	0.0%	COM NEW	25253X207
—	SEASPINE HOLDINGS CORP	253,131	$2.068M	2.2%	$8.17	$8.17	—	COM	81255T108
—	APPLIED GENETIC TECHNOLOGIES	586,969	$1.925M	2.0%	$3.28	$3.28	—	COM	03820J100
—	BAUDAX BIO INC	610,200	$1.513M	1.6%	$2.48	$2.48	—	COM	07160F107
IDXG	INTERPACE BIOSCIENCES INC	178,295	$924K	1.0%	$5.18	$0.50	—	COM	46062X303
—	ANTARES PHARMA INC	151,189	$357K	0.4%	$2.36	$2.36	—	COM	036642106
—	HTG MOLECULAR DIAGNOSTICS	992,641	$323K	0.3%	$0.33	$1.63	—	COM	40434H104
—	RIGEL PHARMACEUTICALS INC	10,000	$16,000	0.0%	$1.60	$1.60	—	COM NEW	766559603